Background. In patients with nephrotic syndrome, the natriuretic effect of
furosemide (FU) is diminished. The effect of coadministration of FU and hum
an albumin (HA) has remained controversial.
Methods. In a double-blind, placebo-controlled study, nine nephrotic patien
ts (six males, 48 +/- 4 years) on standardized sodium chloride intake, in r
andom order on three separate days, received by intravenous administration
for 60 minutes either (a) 60 mg FU plus a sham infusion, (b) 60 mg FU plus
200 mi of a 20% solution of HA, or (c) sham infusion plus 200 mi of a 20 %
solution of HA. Urinary volume, sodium, albumin and FU excretion, renal hem
odynamics, and plasma atrial natriuretic factor concentration were assessed
.
Results. Administration of FU alone significantly (P < 0.01) increased mean
cumulative urinary sodium (259 +/- 30 mmol) and volume excretion (2684 +/-
167 mi) in the first eight hours as compared with the HA infusion alone (1
18 +/- 12 mmol, 1827 +/- 141 mi). The coadministration of FU and HA caused
an even more marked increase (P < 0.01 vs. HA alone) of urinary sodium (312
+/- 28 mmol) and volume excretion (3230 +/- 201 mi); the difference to FU
administration alone was significant (P < 0.05). Plasma atrial natriuretic
factor, serum albumin concentration, and urinary albumin excretion increase
d significantly on both HA infusion days, whereas urinary excretion of FU r
emained unchanged with HA coadministration. Glomerular filtration rate (C-l
n) was not significantly affected by any of the infusion protocols, but eff
ective renal plasma flow (C-PAH) increased significantly on both HA infusio
n days.
Conclusions. Coadministration of HA potentiates the action of FU in patient
s with the nephrotic syndrome, but only modestly. This effect is mediated b
y changes in renal hemodynamics.